NovaBridge Biosciences (NBP)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Transformational Biologics	3.90M
Transformational Biologics Growth	-111.86%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
China	3.90M
China Growth	-111.86%